← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2013Last known activity
Nov 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 6 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT07274462Lead sponsorPhase 4Nov 1, 2025
- NCT07274462Sponsor investigatorPhase 4Nov 1, 2025
- NCT07081126Lead sponsorN/AJul 1, 2025
- NCT07081126Sponsor investigatorN/AJul 1, 2025
- NCT07024238Sponsor investigatorN/AApr 4, 2025
- NCT07024238Lead sponsorN/AApr 4, 2025
- NCT06951581Lead sponsorN/AJan 15, 2024
- NCT06951581Sponsor investigatorN/AJan 15, 2024
- NCT06801886Lead sponsorPhase 3Jan 7, 2020
- NCT06801886Sponsor investigatorPhase 3Jan 7, 2020
- NCT01862978Lead sponsorPhase 4May 1, 2013
- NCT01862978Reponsible party - principal investigatorPhase 4May 1, 2013
Details
- Last known activity
- Nov 1, 2025